Case reports of collision and composite carcinomas of the thyroid: an insight into their origin and clinical significance

Collision and composite carcinomas of the thyroid are extremely rare, and their clinical and biological characteristics are poorly understood. The first case was a 41-year-old female patient with a right thyroid nodule. Pathological diagnosis was papillary thyroid carcinoma (PTC) and medullary thyro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC endocrine disorders 2023-08, Vol.23 (1), p.173-173, Article 173
Hauptverfasser: Ma, Tao, Wang, Ruixiao, Zhou, Xu, Liu, Liqiang, Pan, Aijing, Wang, Hongmei, Huang, Lingyan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Collision and composite carcinomas of the thyroid are extremely rare, and their clinical and biological characteristics are poorly understood. The first case was a 41-year-old female patient with a right thyroid nodule. Pathological diagnosis was papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma composite carcinoma. Surgical treatment was right thyroid lobectomy + left partial thyroidectomy + right central neck lymph node dissection. The second case was a 60-year-old female with bilateral thyroid nodules. Total thyroidectomy was performed, and the pathological diagnosis was thyroid collision carcinoma involving follicular thyroid carcinoma on the left side and PTC on the right side. The clinical, histological and gene changes of collision and composite carcinomas of the thyroid are poorly described. With different biological invasion characteristics, the ideal treatment and the prognosis is currently unknown and individualized treatment is necessary. It is recommended that in composite carcinoma, each cancer is evaluated and treated according to the most severe tumor. Collision carcinoma should be treated as two separate synchronous primary tumors. For both collision and composite carcinomas of the thyroid, the follow-up after treatment should be extensive.
ISSN:1472-6823
1472-6823
DOI:10.1186/s12902-023-01409-z